Article Information
History
- March 11, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Sneha Datwani1,*,
- Rebecca Kalikawe1,*,
- Rachel Waterworth1,3,
- Francis M. Mwimanzi1,
- Richard Liang2,
- Yurou Sang1,
- Hope R. Lapointe2,
- Peter K. Cheung1,2,
- F. Harrison Omondi1,2,
- Maggie C. Duncan1,2,
- Evan Barad1,2,
- Sarah Speckmaier2,
- Nadia Moran-Garcia2,
- Mari L. DeMarco4,5,
- Malcolm Hedgcock6,
- Cecilia T. Costiniuk7,
- Mark Hull2,8,
- Marianne Harris2,9,
- Marc G. Romney4,5,
- Julio S.G. Montaner2,8,
- Zabrina L. Brumme1,2,2,# and
- Mark A. Brockman1,2,3,#
- 1Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada;
- 2British Columbia Centre for Excellence in HIV/AIDS, Vancouver, Canada
- 3Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, Canada;
- 4Department of Pathology and Laboratory Medicine, Providence Health Care, Vancouver, Canada;
- 5Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada
- 6Spectrum Health, Vancouver, Canada
- 7Division of Infectious Diseases and Chronic Viral Illness Service, McGill University Health Centre and Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada
- 8Department of Medicine, University of British Columbia, Vancouver, Canada;
- 9Department of Family Practice, Faculty of Medicine, University of British Columbia, Canada
- ↵#Corresponding authors: MAB, mark_brockman{at}sfu.ca; ZLB, zbrumme{at}sfu.ca
↵* equal contribution
Posted March 11, 2024.
Dynamics of T cell responses to COVID-19 vaccines and breakthrough infection in people living with HIV receiving antiretroviral therapy
